Atara Biotherapeutics
+$0.43 (+3.34%) As of 5:01 PM UTC today
Why Robinhood?
You can buy or sell ATRA and other stocks, options, and ETFs commission-free!
About ATRA
Atara Biotherapeutics, Inc. Common Stock, also called Atara Biotherapeutics, is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. also delivers off-the-shelf treatments to patients with high unmet medical need.
CEO
Pascal Touchon
Employees
437
Headquarters
South San Francisco, California
Founded
2012
ATRA Key Statistics
Market Cap
1.17B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.01M
High Today
$13.62
Low Today
$13.00
Open Price
$13.16
Volume
350.50K
52 Week High
$28.20
52 Week Low
$8.67
Analyst Ratings
80%
of 10 ratings
Buy
80%
Hold
10%
Sell
10%
ATRA Earnings
-$1.44
-$1.21
-$0.97
-$0.74
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.92 per share
Actual
-$0.86 per share